Norges Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Norges Bank’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,252,775	Closed	-$896M	–	61
2025 Q4	$896M	Buy	+2,252,775	New	+$997M	0.1%	182
2025 Q3	–	Sell	-2,032,680	Closed	-$663M	–	70
2025 Q2	$663M	Sell	2,032,680 -103,344	-5%	-$28.6M	0.08%	225
2025 Q1	$577M	Sell	2,136,024 -320,058	-13%	-$82.3M	0.08%	228
2024 Q4	$578M	Buy	2,456,082 +80,547	+3%	+$21.2M	0.08%	235
2024 Q3	$653M	Buy	2,375,535 +78,754	+3%	+$20.5M	0.09%	202
2024 Q2	$558M	Buy	2,296,781 +4,127	+0.2%	+$652K	0.08%	219
2024 Q1	$343M	Buy	2,292,654 +252,856	+12%	+$42.2M	0.05%	314
2023 Q4	$390M	Buy	2,039,798 +846,232	+71%	+$144M	0.07%	255
2023 Q3	$211M	Buy	1,193,566 +490,212	+70%	+$93.5M	0.04%	362
2023 Q2	$134M	Sell	703,354 -818,058	-54%	-$162M	0.03%	497
2023 Q1	$305M	Buy	1,521,412 +508,566	+50%	+$107M	0.07%	274
2022 Q4	$241M	Sell	1,012,846 -205,338	-17%	-$43.8M	0.06%	314
2022 Q3	$244M	Sell	1,218,184 -66,593	-5%	-$12.7M	0.06%	289
2022 Q2	$187M	Sell	1,284,777 -10,310	-0.8%	-$1.46M	0.05%	344
2022 Q1	$211M	Buy	1,295,087 +25,896	+2%	+$3.95M	0.05%	370
2021 Q4	$215M	Buy	1,269,191 +274,303	+28%	+$51M	0.04%	385
2021 Q3	$188M	Buy	994,888 +100,136	+11%	+$18.8M	0.04%	412
2021 Q2	$152M	Sell	894,752 -67,552	-7%	-$9.89M	0.03%	492
2021 Q1	$136M	Sell	962,304 -76,684	-7%	-$11.5M	0.03%	519
2020 Q4	$135M	Sell	1,038,988 -1,361	-0.1%	-$182K	0.03%	490
2020 Q3	$151M	Buy	1,040,349 +138,030	+15%	+$19.6M	0.04%	403
2020 Q2	$134M	Sell	902,319 -85,446	-9%	-$11.5M	0.04%	409
2020 Q1	$108M	Sell	987,765 -15,448	-2%	-$1.78M	0.04%	409
2019 Q4	$116M	Sell	1,003,213 -121,009	-11%	-$12.1M	0.03%	488
2019 Q3	$90.4M	Sell	1,124,222 -14,780	-1%	-$1.17M	0.03%	558
2019 Q2	$82.6M	Sell	1,139,002 -7,867	-0.7%	-$604K	0.03%	598
2019 Q1	$107M	Sell	1,146,869 -145,507	-11%	-$12.2M	0.03%	471
2018 Q4	$94.2M	Buy	1,292,376 +159,445	+14%	+$12.3M	0.04%	465
2018 Q3	$99.2M	Buy	1,132,931 +314,695	+38%	+$31.7M	0.03%	504
2018 Q2	$80.6M	Buy	818,236 +14,273	+2%	+$1.42M	0.03%	572
2018 Q1	$95.8M	Buy	803,963 +61,702	+8%	+$7.95M	0.03%	490
2017 Q4	$94.3M	Buy	742,261 +187,242	+34%	+$23.5M	0.03%	493
2017 Q3	$65.2M	Sell	555,019 -189,396	-25%	-$16.2M	0.02%	630
2017 Q2	$59.4M	Buy	744,415 +100,000	+16%	+$6.39M	0.02%	642
2017 Q1	$33M	Sell	644,415 -20,248	-3%	-$936K	0.01%	1011
2016 Q4	$24.9M	Buy	664,663 +116,894	+21%	+$4.89M	0.01%	1167
2016 Q3	$35.5M	Buy	547,769 +87,008	+19%	+$6.14M	0.02%	827
2016 Q2	$25.6M	Buy	460,761 +31,380	+7%	+$1.98M	0.01%	1047
2016 Q1	$27M	Sell	429,381 -168,776	-28%	-$11.2M	0.01%	972
2015 Q4	$56.3M	Sell	598,157 -66,811	-10%	-$6.19M	0.03%	559
2015 Q3	$53.4M	Buy	664,968 +91,048	+16%	+$10.1M	0.03%	552
2015 Q2	$68.8M	Sell	573,920 -21,374	-4%	-$2.55M	0.03%	512
2015 Q1	$62.2M	Buy	595,294 +42,633	+8%	+$4.32M	0.03%	559
2014 Q4	$53.6M	Buy	552,661 +44,531	+9%	+$4.13M	0.03%	610
2014 Q3	$39.7M	Sell	508,130 -508,130	-50%	-$32.8M	0.02%	732
2014 Q2	$64.2M	Buy	1,016,260 +622,369	+158%	+$37M	0.02%	845
2014 Q1	$26.4M	Hold	393,891	–	–	0.01%	950
2013 Q4	$25.3M	Buy	393,891 +15,873	+4%	+$947K	0.01%	964
2013 Q3	$24.2M	Buy	378,018 +61,614	+19%	+$3.07M	0.01%	955
2013 Q2	$9.81M	Buy	+316,404	New	+$8.42M	0.01%	1483